Fiji Kava Limited (ASX:FIJ) Fiji Kava Launches on Alibaba's Tmall Platform
Fiji Kava Limited (ASX:FIJ) to increase its presence in China as it launches on Alibaba's Tmall e-commerce platform.
Companies in the News
Ag Biotechnology
Fiji Kava Limited (ASX:FIJ) Quarterly Activity Report
Fiji Kava Ltd (ASX:FIJ) is a health and wellness company with operations in Australia, Fiji and the USA. The company produces natural products to reduce anxiety, promote relaxation, improve sleep and support sports recovery and performance.
Fiji Kava Limited (ASX:FIJ) Completes Purchase of Danodan CBD Tincture Business in USA
Fiji Kava Limited (ASX:FIJ) has completed the acquisition of Danodan Hempworks LLC, including its CBD extraction US Patent 10,716,819, purchased from Danodan Founder, Mr Daniel Stoops (together, "Danodan").
FijiKava Ltd (ASX:FIJ) Signs LOI to Buy Danodan CBD Tincture Business in USA and Reposition American Business as the Calmer Co.
FijiKava Ltd (ASX:FIJ) today announced signing of indicative letters of intent for FijiKava's wholly owned subsidiary, Fiji Kava Inc, USA to acquire the assets of The Whole Plant Company.
Medlab Clinical Ltd (ASX:MDC) Executes Master Services Agreement with WEP Clinical Ltd
Medlab Clinical Ltd (ASX:MDC), an Australian biotech using delivery platforms to enhance medicines is pleased to announce the execution of a Master Services Agreement with WEP Clinical Ltd for the exclusive development and delivery of Named Patient Programmes
AusCann Group Holdings Ltd (ASX:AC8) and CannPal Enter Into Scheme of Arrangement
AusCann Group Holdings Ltd (ASX:AC8), an Australian based pharmaceutical company focused on the development, production and distribution of cannabinoid-based medicines within Australia and internationally, is pleased to announce that it has entered into a scheme implementation deed (SID) with CannPal Animal Therapeutics Limited.
Cann Global Limited (ASX:CGB) Quarterly Activities and Cashflow Report
Cann Global continued to drive sales throughout the quarter resulting in cash receipts from customers of $333k up 54.6% on the prior corresponding period, but lower than the prior quarter due to shipping delays and therefore delayed payment on contracted sales.
◂Previous Page
Ag Biotechnology Next Page▸
Banking & Finance
- NSX Limited (ASX:NSX) Company Update
- ASIC vs iSignthis Ltd and Nickolas John Karantzis
- NSX Limited (ASX:NSX) Appointment of Managing Director and CEO - Max Cunningham
Social Media
